(Q38066385)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23229448%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

review article

1 reference

title

Global trends, potential mechanisms and early detection of organ damage in SLE (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23229448%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23229448%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Anselm Mak

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23229448%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Chak-Sing Lau

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23229448%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

language of work or name

English

0 references

publication date

11 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23229448%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Rheumatology

20 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23229448%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23229448%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23229448%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

301-310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23229448%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrrheum.2012.208

20 February 2020

exact match

0 references

cites work

The socioeconomic burden of SLE.

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Skin damage occurs early in systemic lupus erythematosus and independently of disease duration in Brazilian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Anti-DNA antibodies in the pathogenesis of lupus nephritis--the emerging mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Anti-DNA antibody induction of protein kinase C phosphorylation and fibronectin synthesis in human and murine lupus and the effect of mycophenolic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Autoantibodies to dsDNA cross-react with the arginine-glycine-rich domain of heterogeneous nuclear ribonucleoprotein A2 (hnRNP A2) and promote methylation of hnRNP A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Raised plasma levels of asymmetric dimethylarginine are associated with cardiovascular events, disease activity, and organ damage in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Effect of asymmetric dimethylarginine on osteoblastic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Dual roles of immunoregulatory cytokine TGF-beta in the pathogenesis of autoimmunity-mediated organ damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Levels of transforming growth factor-beta are low in systemic lupus erythematosus patients with active disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Association of mannose-binding lectin gene polymorphisms with antiphospholipid syndrome, cardiovascular disease and chronic damage in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Interleukin-10 gene polymorphisms are associated with the SLICC/ACR Damage Index in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Oestrogen receptor {alpha} gene polymorphisms in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Antibodies and the Brain: Lessons from Lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Human lupus autoantibodies against NMDA receptors mediate cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Anti-alpha-internexin autoantibody from neuropsychiatric lupus induce cognitive damage via inhibiting axonal elongation and promote neuron apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Neuropsychiatric disease in Sjögren's syndrome: anti-ribosomal P and anti-neuronal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Functional MRI in NPSLE patients reveals increased parietal and frontal brain activation during a working memory task compared with controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

A prospective functional MRI study for executive function in patients with systemic lupus erythematosus without neuropsychiatric symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Dysfunctional cortico-basal ganglia-thalamic circuit and altered hippocampal-amygdala activity on cognitive set-shifting in non-neuropsychiatric systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Performance of subclinical arterial disease detection as a screening test for coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Premature coronary-artery atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Pattern of arterial calcification in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Prognostic value of coronary vascular endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Endothelium-dependent but not endothelium-independent flow-mediated dilation is significantly reduced in patients with systemic lupus erythematosus without vascular events: a metaanalysis and metaregression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Concise review: Circulating endothelial progenitor cells for vascular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Endothelial progenitor cell dysfunction in type 1 diabetes: another consequence of oxidative stress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Pre-procedural atorvastatin mobilizes endothelial progenitor cells: clues to the salutary effects of statins on healing of stented human arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Urinary vascular cell adhesion molecule, but not neutrophil gelatinase-associated lipocalin, is associated with lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Relationship between lupus nephritis activity and the serum level of soluble VCAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Urinary biomarkers in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Urinary TWEAK and the activity of lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Urine biomarkers predict the cause of glomerular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Biomarkers of lupus nephritis determined by serial urine proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Assessment of individual fracture risk: FRAX and beyond.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Assessment of bone remodelling in childhood-onset systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Mortality in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrual.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

The causes of death in Korean patients with systemic lupus erythematosus over 11 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Clinical Risk Factors for Fractures in Multi-Ethnic Women: The Women's Health Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Global trend of survival and damage of systemic lupus erythematosus: meta-analysis and meta-regression of observational studies from the 1950s to 2000s

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Autoantibodies closely relate to the elevation level of in vivo hydrogen peroxide and tissue damage in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Role of transforming growth factor-beta 1 in glomerulonephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Systemic lupus erythematosus in a multiethnic US cohort: XXXIV. Deficient mannose-binding lectin exon 1 polymorphisms are associated with cerebrovascular but not with other arterial thrombotic events

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Polymorphisms in the promoter region of RANTES in Han Chinese and their relationship with systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

NR2-reactive antibody decreases cell viability through augmentation of Ca(2+) influx in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Neuronal antibodies and cognitive function in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Cognitive impairment and autoantibodies in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Functional magnetic resonance imaging assessment of cognitive function in childhood-onset systemic lupus erythematosus: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Incremental predictive value of vascular assessments combined with the Framingham Risk Score for prediction of coronary events in subjects of low-intermediate risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Burden of carotid atherosclerosis in patients with stroke: relationships with circulating endothelial progenitor cells and hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Comparative study on circulating endothelial progenitor cells in systemic lupus erythematosus patients at active stage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Elevated urinary VCAM-1, P-selectin, soluble TNF receptor-1, and CXC chemokine ligand 16 in multiple murine lupus strains and human lupus nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Significantly higher estimated 10-year probability of fracture in lupus patients with bone mineral density comparable to that of healthy individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

High Impact of Antiphospholipid Syndrome on Irreversible Organ Damage and Survival of Patients With Systemic Lupus Erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.208

Lumbar spine bone mineral density predicts endothelial reactivity in patients with systemic lupus erythematosus.

31 March 2020

1 reference

12 December 2020

Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids.

1 reference

12 December 2020

Brachial endothelial function is impaired in patients with systemic lupus erythematosus

1 reference

12 December 2020

Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death.

1 reference

12 December 2020

Damage accrual in southern Chinese patients with systemic lupus erythematosus.

1 reference

12 December 2020

Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force

1 reference

12 December 2020

Asymmetric dimethylarginine is a marker of poor prognosis and coronary calcium in systemic lupus erythematosus.

1 reference

12 December 2020

Effect of age on bone mineral density and the serum concentration of endogenous nitric oxide synthase inhibitors in rats

1 reference

12 December 2020

Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus.

1 reference

12 December 2020